-2.75 (-0.17%) The Exchange has sought clarification from Sun Pharmaceutical Industries on December 07, 2016, with reference to ET NOW dated December 07, 2016, quoting ‘USFDA informs that Halol issued 14 page Form 483 post inspection’.
The above information is a part of company’s filings submitted to BSE.